Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 122 Records) |
| Query Trace: Neoplasms and AHR[original query] |
|---|
| The mutation profiles of cell-free DNA in patients with oesophageal squamous cell carcinoma who were responsive and non-responsive to neoadjuvant chemotherapy. Journal of thoracic disease 2020 Aug 12 (8): 4274-4283. Zhang Ruixiang, Hu Ying, Zhou Tao, Han Wenbo, Liu Yang, Qian Juanjuan, Chen Yanhui, Liu Xianben, Liu Shilei, Yu Yongkui, Zeng Hui, Zhang Henghui, Li Y |
| Lack of association between multiple polymorphisms in aryl hydrocarbon receptor (AhR) gene and cancer susceptibility. Environmental health and preventive medicine 2020 Dec 25 (1): 79. Li He, Luo Li, Wang Dan, Duan Jun, Zhang R |
| Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE). Cancer genetics 2021 9 258-259 61-68. Swami Nishwant, Hwang William L, Guo Jimmy A, Hoffman Hannah, Abramowitz Matthew C, Elbakouny Ziad, Beltran Himisha, Chipidza Fallon, Choueiri Toni, Pra Alan Dal, Huang Franklin, Kaochar Salma, Kantoff Philip, Kim Daniel W, Kishan Amar U, Kobetz Erin, Marinac Catherine, Mucci Lorelei A, Muralidhar Vinayak, Pollack Alan, Sanford Nina N, Schaeffer Edward M, Spratt Daniel E, Zhao Shuang G, Rebbeck Timothy R, Nguyen Paul L, Feng Felix Y, Mahal Brandon A, Alshalalfa Mohamm |
| Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 7 27 (18): 5131-5140. Luo Jia, Martucci Victoria L, Quandt Zoe, Groha Stefan, Murray Megan H, Lovly Christine M, Rizvi Hira, Egger Jacklynn V, Plodkowski Andrew J, Abu-Akeel Mohsen, Schulze Isabell, Merghoub Taha, Cardenas Eduardo, Huntsman Scott, Li Min, Hu Donglei, Gubens Matthew A, Gusev Alexander, Aldrich Melinda C, Hellmann Matthew D, Ziv El |
| The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study. Frontiers in oncology 2021 6 11 642768. Tryggvadottir Helga, Sandén Emma, Björner Sofie, Bressan Alessandra, Ygland Rödström Maria, Khazaei Somayeh, Edwards Dean P, Nodin Björn, Jirström Karin, Isaksson Karolin, Borgquist Signe, Jernström Hele |
| Genetic Polymorphisms in Activating Transcription Factor 3 Binding Site and the Prognosis of Early-Stage Non-Small Cell Lung Cancer. Oncology 2021 2 99 (5): 336-344. Kang Hyo-Gyoung, Park Ji Eun, Lee Shin Yup, Choi Jin Eun, Do Sook Kyung, Hong Mi Jeong, Lee Jang Hyuck, Jeong Ji Yun, Do Young Woo, Lee Eung Bae, Shin Kyung Min, Lee Won Ki, Choi Sun Ha, Lee Yong Hoon, Seo Hye Won, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Cho Sukki, Jheon Sanghoon, Park Jae Yo |
| Risk SNP-induced lncRNA-SLCC1 drives colorectal cancer through activating glycolysis signaling. Signal transduction and targeted therapy 2021 2 6 (1): 70. Yan Tingting, Shen Chaoqin, Jiang Penglei, Yu Chenyang, Guo Fangfang, Tian Xianglong, Zhu Xiaoqiang, Lu Shiyuan, Han Bingshe, Zhong Ming, Chen Jinxian, Liu Qiang, Chen Yingxuan, Zhang Junfang, Hong Jie, Chen Haoyan, Fang Jing-Yu |
| Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis. Clinical lung cancer 2021 Jan . Chan Sze Wah Samuel, Smith Elliot, Aggarwal Reenika, Balaratnam Karmugi, Chen RuiQi, Hueniken Katrina, Fazelzad Rouhi, Weiss Jessica, Jiang Shirley, Shepherd Frances A, Bradbury Penelope A, Sacher Adrian G, Leighl Natasha B, Xu Wei, Brown M Catherine, Eng Lawson, Liu Geoffr |
| Pretreatment neutrophil-to-lymphocyte ratio as an important prognostic marker in stage III locally advanced non-small cell lung cancer: confirmatory results from the PROCLAIM phase III clinical trial. Journal of thoracic disease 2021 11 13 (10): 5617-5626. Biswas Tithi, Gawdi Rohin, Jindal Charulata, Iyer Sharanya, Kang Kylie H, Bajor David, Machtay Mitchell, Choi Yuk Ming, Efird Jimmy |
| Impact of immune checkpoint gene CD155 Ala67Thr and CD226 Gly307Ser polymorphisms on small cell lung cancer clinical outcome. Scientific reports 2021 Jan 11 (1): 1794. Lee Jang Hyuck, Yoo Seung Soo, Hong Mi Jeong, Choi Jin Eun, Kim Soyoun, Kang Hyo-Gyoung, Do Sook Kyung, Kim Ji Hyun, Baek Sun Ah, Lee Won Kee, Do Yoo Jae, Choi Sun Ha, Lee Yong Hoon, Seo Hyewon, Lee Jaehee, Lee Shin Yup, Cha Seung Ick, Kim Chang Ho, Park Jae Yo |
| Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL. Annals of oncology : official journal of the European Society for Medical Oncology 2021 1 32 (4): 488-499. Martin M, Zielinski C, Ruiz-Borrego M, Carrasco E, Turner N, Ciruelos E M, Muñoz M, Bermejo B, Margeli M, Anton A, Kahan Z, Csöszi T, Casas M I, Murillo L, Morales S, Alba E, Gal-Yam E, Guerrero-Zotano A, Calvo L, de la Haba-Rodriguez J, Ramos M, Alvarez I, Garcia-Palomo A, Huang Bartlett C, Koehler M, Caballero R, Corsaro M, Huang X, Garcia-Sáenz J A, Chacón J I, Swift C, Thallinger C, Gil-Gil |
| SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 9 28 (22): 4917-4925. Swami Umang, Graf Ryon P, Nussenzveig Roberto H, Fisher Virginia, Tukachinsky Hanna, Schrock Alexa B, Li Gerald, Ross Jeffrey S, Sayegh Nicolas, Tripathi Nishita, Mathew Thomas Vinay, Oxnard Geoffrey R, Antonarakis Emmanuel S, Agarwal Neer |
| PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients. Scientific reports 2022 6 12 (1): 9753. Hsu Kuo-Hsuan, Tseng Jeng-Sen, Yang Tsung-Ying, Chen Kun-Chieh, Su Kang-Yi, Yu Sung-Liang, Chen Jeremy J W, Huang Yen-Hsiang, Chang Gee-Ch |
| Proton pump inhibitors reduce the survival of advanced lung cancer patients with therapy of gefitinib or erlotinib. Scientific reports 2022 4 12 (1): 7002. Lee Chia-Han, Shen Mei-Chiou, Tsai Ming-Ju, Chang Jung-San, Huang Yaw-Bin, Yang Yi-Hsin, Hsieh Kun-P |
| AHR gene expression and the polymorphism rs2066853 are associated with clinicopathological parameters in colorectal carcinoma. Human pathology 2022 Feb . Cheng Tracie, Gamage Sujani Madhurika Kodagoda, Hewage Dinu, Lu Cu-Tai, Aktar Sharmin, Gopalan Vinod, Lam Alfred King-Y |
| Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer. European journal of medical research 2022 Jan 27 (1): 14. Rosenberger Albert, Muttray Nils, Hung Rayjean J, Christiani David C, Caporaso Neil E, Liu Geoffrey, Bojesen Stig E, Le Marchand Loic, Albanes Demetrios, Aldrich Melinda C, Tardon Adonina, Fernández-Tardón Guillermo, Rennert Gad, Field John K, Davies Michael P A, Liloglou Triantafillos, Kiemeney Lambertus A, Lazarus Philip, Wendel Bernadette, Haugen Aage, Zienolddiny Shanbeh, Lam Stephen, Schabath Matthew B, Andrew Angeline S, Duell Eric J, Arnold Susanne M, Goodman Gary E, Chen Chu, Doherty Jennifer A, Taylor Fiona, Cox Angela, Woll Penella J, Risch Angela, Muley Thomas R, Johansson Mikael, Brennan Paul, Landi Maria Teresa, Shete Sanjay S, Amos Christopher I, Bickeböller Heike, |
| Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival. Cancer medicine 2022 11 . Stabellini Nickolas, Tomlinson Benjamin, Cullen Jennifer, Shanahan John, Waite Kristin, Montero Alberto J, Barnholtz-Sloan Jill S, Hamerschlak Nels |
| Association of xenobiotic-metabolizing genes polymorphisms with cervical cancer risk in the Tunisian population. Molecular biology reports 2022 11 50 (2): 949-959. Helaoui Ahlem, Sfar Sana, Boudhiba Najet, Dehghanian Fariba, Dehbashi Moein, Bouchahda Haifa, Hojati Zohreh, Kenani Abderrao |
| Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non-small cell lung cancer. Thoracic cancer 2022 Oct . Choi Sun Ha, Do Sook Kyung, Lee Shin Yup, Choi Jin Eun, Kang Hyo-Gyoung, Hong Mi Jeong, Lee Jang Hyuck, Lee Won Kee, Jeong Ji Yun, Shin Kyung Min, Do Young Woo, Lee Eung Bae, Park Ji Eun, Lee Yong Hoon, Seo Hyewon, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Park Jae Yo |
| Coffee consumption and its interaction with the genetic variant AhR rs2066853 in colorectal cancer risk: a case-control study in Korea. Carcinogenesis 2022 Jan . Lu Y-Thanh, Gunathilake Madhawa, Lee Jeonghee, Kim Youngyo, Oh Jae Hwan, Chang Hee Jin, Sohn Dae Kyung, Shin Aesun, Kim Jeongse |
| Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancer. Scientific reports 2022 Jun 12 (1): 10081. Vlaar Judith M, Borgman Anouska, Kalkhoven Eric, Westland Denise, Besselink Nicolle, Shale Charles, Faltas Bishoy M, Priestley Peter, Kuijk Ewart, Cuppen Edw |
| Oxidative stress-related genetic variation and antioxidant vitamin intake in intact and ruptured abdominal aortic aneurysm: a Swedish population-based retrospective cohort study. European journal of preventive cardiology 2023 9 . Sakshi Vats, Kristina Sundquist, Jan Sundquist, Naiqi Zhang, Xiao Wang, Stefan Acosta, Anders Gottsäter, Ashfaque A Mem |
| Lipid metabolism pathway genes and lung cancer: ACADSB rs12220683G>C is associated with better survival outcome in patients with non-small cell lung cancer. Oncology 2023 8 . Seung Soo Yoo, Sook Kyung Do, Jin Eun Choi, Hyo-Gyoung Kang, Mi Jeong Hong, Jang Hyuck Lee, Won Kee Lee, Young Woo Do, Eung Bae Lee, Ji Eun Park, Sun Ha Choi, Hyewon Seo, Yong Hoon Lee, Jaehee Lee, Shin Yup Lee, Seung Ick Cha, Chang Ho Kim, Jae Yong Pa |
| Variation in KRAS/NRAS/BRAF-Mutation Status by Age, Sex, and Race/Ethnicity Among a Large Cohort of Patients with Metastatic Colorectal Cancer (mCRC). Journal of gastrointestinal cancer 2023 6 . Benjamin D Booker, Sarah C Markt, Fredrick R Schumacher, Johnie Rose, Greg Cooper, J Eva Selfridge, Siran M Korouki |
| Prognostic significance of L1CAM expression in addition to ProMisE in endometrial cancer. Gynecologic oncology 2023 5 174 231-238. Junhwan Kim, Se Ik Kim, Nae Ry Kim, Hyojin Kim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Cheol Lee, Maria L |
| Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors. European journal of cancer (Oxford, England : 1990) 2023 4 187 15-24. Paolo Manca, Francesca Corti, Rossana Intini, Giacomo Mazzoli, Rosalba Miceli, Marco Maria Germani, Francesca Bergamo, Margherita Ambrosini, Eleonora Cristarella, Riccardo Cerantola, Chiara Boccaccio, Gianmarco Ricagno, Filippo Ghelardi, Giovanni Randon, Giuseppe Leoncini, Massimo Milione, Matteo Fassan, Chiara Cremolini, Sara Lonardi, Filippo Pietranton |
| Evaluating whether KRAS/BRAF mutation status, anaemia and obstruction are associated with recurrence and mortality in non-metastatic colorectal cancer. ANZ journal of surgery 2023 4 . Karolina Juszczyk, Mohamed Zaafer Afzal, Timothy Ganguly, Thu-Lan Kelly, Robyn Zeelie, Elizabeth Mary Ann Murp |
| Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib. Cancers 2023 4 15 (7): . Tsai Ming-Ju, Hung Jen-Yu, Ma Juei-Yang, Tsai Yu-Chen, Wu Kuan-Li, Lee Mei-Hsuan, Kuo Chia-Yu, Chuang Cheng-Hao, Lee Tai-Huang, Lee Yen-Lung, Huang Chun-Ming, Shen Mei-Chiou, Yang Chih-Jen, Chong Inn-W |
| Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer. BMC cancer 2023 4 23 (1): 330. Ma Sung Jun, Gill Jasmin, Yendamuri Keerti, Chatterjee Udit, Waldman Olivia, Dunne-Jaffe Cynthia, Fekrmandi Fatemeh, Shekher Rohil, Iovoli Austin, Yao Song, Oladeru Oluwadamilola T, Singh Anurag |
| Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinoma. Journal of Cancer 2023 1 13 (15): 3701-3709. Hong Mi Jeong, Park Ji Eun, Lee Shin Yup, Lee Jang Hyuck, Choi Jin Eun, Kang Hyo-Gyoung, Do Sook Kyung, Jeong Ji Yun, Shin Kyung Min, Lee Won Ki, Seok Yangki, Choi Sun Ha, Lee Yong Hoon, Seo Hyewon, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Park Jae Yo |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: